Filing Summary
Registrant and period: The filing identifies the registrant as Jupiter Wellness, Inc., not BONK, Inc. It is a Form 8-K dated December 30, 2022, reporting actions taken under the company’s 2022 Equity Incentive Plan.
Material Event
- Stockholders approved the 2022 Equity Incentive Plan at a special meeting held December 22, 2022.
- On December 30, 2022, the company granted directors and officers immediately vested options to purchase an aggregate of 2,850,000 common shares.
- The options are exercisable for five years from the grant date.
- Brian S. John and Glynn Wilson each received 1,050,000 options, at exercise prices of $0.836 and $0.76 per share, respectively.
- CFO Doug McKinnon received 500,000 options at $0.76 per share.
- Nancy Torres Kauffman, Gary Hermann, Christopher Melton, and Skander Fani each received 50,000 options at $0.76 per share.
- The $0.76 exercise price was the company’s closing common-stock price on December 29, 2022.
- The company also granted 50,000 common shares to a former director serving as an advisor.
Financial Metrics and Liquidity
This Form 8-K does not report revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating financial metrics. It also does not provide the accounting fair value or expected expense associated with the equity awards.
Changes Versus Prior Period
The filing does not provide comparative-period financial information. The material change disclosed is the issuance of equity-based compensation and an additional 50,000 common shares to an advisor.
Management Commentary, Risks, and Unusual Items
No management outlook or operating commentary is included. Investors should consider potential dilution from the 2,850,000 options and the 50,000 shares granted to the advisor. The filing text does not state whether the options contain additional performance conditions or provide the accounting treatment for the awards.
Investor Verification Checklist
- Verify the correct issuer: the supplied filing names Jupiter Wellness, Inc., while the request metadata identifies BONK, Inc.
- Confirm the final share count, option terms, vesting status, expiration dates, and exercise prices in the company’s equity-plan disclosures.
- Assess the potential dilution from the options and advisor shares.
- Review subsequent filings for the accounting expense, fair-value assumptions, exercises, forfeitures, or modifications related to these awards.
- Confirm whether the 2022 Equity Incentive Plan had sufficient authorized shares for these grants.